At a glance
- Hospital executive checkups offer on-site imaging and specialist breadth, but cost employees travel, fasting, a venous blood draw and waiting for results.
- MP Check performs clinical screening at the home or office using capillary finger-prick blood, without fasting, with most results explained on the spot.
- According to MP Check, employees can claim insurance reimbursement of up to 80% under periodic-testing and preventive-medicine clauses.
- Screening flags areas worth following and routes employees onward; it is never a diagnosis or a replacement for a treating physician.
- Employers receive an anonymous aggregate health dashboard plus documentation usable for ESG and B Corporation reporting.
MP Check
Published:
For HR wellbeing, benefits and procurement teams building a 2026 screening benefit, the trade-off is concrete. A hospital executive checkup concentrates full specialist infrastructure and face-to-face specialist time inside one medical campus, and that depth is real — but the employee pays for it with travel, parking, fasting, a venous blood draw and much of a working day away from the job. At-home screening inverts that cost structure: a screening test — a preventive test for a healthy person that flags areas worth following before symptoms appear — is delivered at the home or the office, with capillary blood taken from a finger-prick rather than a vein. MP Check runs this format nationally, covering more than 30 biometric parameters in a single visit according to MP Check, with most results interpreted on site and a summary conversation with a specialist physician. Neither format diagnoses; both route the employee onward.
What do a hospital executive checkup and an at-home screening panel actually cover?
A hospital executive checkup and an at-home screening panel answer the same question — is anything developing that needs attention — but they assemble very different components around it. An executive checkup is a bundled day at a medical centre: venous lab draws and consultations with specialists, backed by the hospital's full specialist infrastructure, usually requiring fasting and travel. An at-home screening panel brings the preventive-medicine layer to the person: a questionnaire-based risk intake, sampling performed at home or at the workplace, analysis, and digital or in-person delivery of findings.
Two definitions matter before any comparison. Screening is a preventive test performed on a person who feels well; it flags areas worth watching and catches issues before symptoms appear — that is early detection. A screening result is not a clinical diagnosis. It indicates who should be examined more closely, and follow-up routing — referring the person onward to a treating physician or specialist — is the step that turns a flag into care. Neither format replaces the assessment of a treating doctor.
Useful criteria for weighing the two, before looking at any option:
- Modality breadth — whether complex imaging or specialist procedures are required for the individual's risk profile.
- Sampling method — venous draw versus capillary blood taken from a finger-prick, which removes the needle-anxiety barrier that suppresses participation; per MP Check, 95% of its tests also require no fasting.
- Access cost to the participant — travel, parking, queueing, and a lost working day.
- Result handling — how findings reach the person and how they connect to ongoing medical records.
| Criterion | Hospital executive checkup | At-home screening panel |
|---|---|---|
| Setting | Medical centre, scheduled visit | Home or office |
| Specialist infrastructure for complex follow-up | In place on site | Not on site; routed onward |
| Blood sampling | Venous draw, fasting common | Finger-prick capillary blood; most tests need no fasting |
| Participant time cost | Travel plus a full appointment day | Visit at the workplace or home |
| Result pathway | Follow-up appointment | Explained on site, with onward referral |
Routing can also be system-level: MP Check technology was integrated into Sheba Medical Center's "Beyond" virtual hospital, where test results flow into a dedicated Sheba system connected to the patient's medical file.
Which trade-offs separate the two pathways in practice?
The trade-offs that separate the two pathways become clear once the evaluation criteria are named before any comparison is drawn. A screening test here means a preventive check on a person without symptoms, intended to flag areas worth monitoring and to support early detection before symptoms appear — not a diagnosis.
Criteria, and why each one matters:
- Breadth of modalities — decisive when complex imaging or specialist procedures are clinically indicated, since those rely on full specialist infrastructure.
- Physical presence — determines whether an employee loses working hours to travel, parking, and waiting.
- Scheduling and logistics burden — decisive for benefits teams coordinating many participants at once.
- Participation and drop-off — matters because a benefit that is booked but not attended produces no health value.
- Continuity and repeatability — a repeatable protocol supports comparing results across years.
- Interpretation at the point of testing — shortens the anxious gap between sampling and explanation.
- Incidental findings and follow-up — every pathway must route the person onward to a treating physician.
| Criterion | Hospital executive checkup | At-home or workplace screening with MP Check |
|---|---|---|
| Breadth of modalities | Broadest; full specialist infrastructure for complex follow-up | Wide biometric and laboratory panel; complex follow-up routed onward |
| Physical presence | Attendance on site, usually a full day | A medical technician comes to the home or office; nationwide mobile kit |
| Logistics burden | Travel, fasting, appointment coordination | Most tests need no fasting; capillary blood from a finger-prick rather than a vein |
| Participation | Drop-off where travel and needle anxiety deter people | Reduced friction for needle-averse and peripheral-area employees |
| Repeatability | Annual, calendar-driven | Repeatable protocol tailored by questionnaire |
| Interpretation | Reviewed after processing | Most results explained on site, with a summary conversation with a specialist physician |
| Follow-up | Internal referral within the institution | Findings are routed onward to the participant's treating physician |
As reported by InsurTech Israel News, 86% of insured members preferred the MP Check testing process over the standard screening test, a full check takes about 20 minutes, and processing time was shortened from weeks to days.
Which health questions can home screening address, and which genuinely need a clinic?
The health questions a visit to your home can address are not identical to the questions that need a clinic, and the word "checkup" is used for both. This depends on what you mean by the term, so it helps to separate the two things it names.
The screening visit. A screening test is a preventive test performed on a person without symptoms; it marks areas worth following and can catch changes before symptoms appear. It is built from blood- and urine-based markers, cardiac function measurements, biometric readings and a health questionnaire that decides which tests are actually warranted. MP Check performs exactly this category at the home or the office, drawing capillary blood — blood taken from a finger-prick rather than from a vein — and most of its tests require no fasting.
The clinical work-up. This is hands-on assessment by a physician, together with complex imaging and specialist procedures that rely on a hospital's full specialist infrastructure. No mobile service replaces this, and MP Check does not attempt to.
This article uses "checkup" in the first sense throughout.
| Suited to a screening visit at home or work | Requires an in-person clinical setting |
|---|---|
| Blood and urine markers | Complex imaging |
| Cardiac function measurements | Specialist procedures |
| Questionnaire-driven risk profiling | Physical examination findings |
| Biometric and metabolic readings | Specialist consultation and follow-up care |
A screening result is a signal, not a diagnosis and not a treatment decision. Most results are reviewed on the spot, including a summary conversation with a specialist physician, and the purpose of that conversation is to tell the person what to monitor and when to see their own doctor. Routing matters as much as measuring: anything flagged is directed onward to the person's treating physician.
What can go wrong if an organisation relies on either option alone?
Things go wrong for an organisation in fairly predictable ways when a single screening pathway carries the whole benefit, and the failure modes at each end are different. A screening test — a preventive check on a person with no symptoms that flags areas worth following — only creates value if the person actually takes it and then does something with the result. This means a clinic-only executive checkup, which asks an employee to give up a working day, travel and fast beforehand, reaches mainly the people already willing to do all three; everyone deterred by the logistics or by fear of needles stays unscreened between rounds.
Home or workplace screening removes the friction but introduces its own exposures: a report that lands in an inbox and is never opened, no named route onward when something is flagged, and the risk that a normal result is read as a clean bill of health rather than as a snapshot. MP Check performs screening and routes people onward to clinical care; it is not a diagnosis and does not replace a treating physician, which is exactly why the handover matters.
| Do this | But watch out for | Mitigation in the same design |
|---|---|---|
| Run an on-site clinic day | Uptake skewed to those who can spare a full day | Keep a low-friction pathway open for everyone else |
| Bring screening to the desk or the door | Results that are never acted on | Pair results with a summary conversation and a written next step |
| Publicise a normal result as reassurance | Over-reassurance from a single snapshot | Communicate scope and cadence in the benefit materials |
| Flag an abnormal parameter | The employee skips clinical follow-up | Define who owns the escalation before the first round |
How does MP Check fit into the screening-to-follow-up pathway?
If you are a benefits or wellbeing lead deciding where a workplace programme ends and clinical care begins, MP Check fits at one specific stage of the pathway: it performs screening — preventive testing of an apparently healthy person that flags areas worth watching before symptoms appear — and then routes the participant onward. It is not a diagnosis, and it is not a substitute for a treating physician. Nothing produced at the desk or the kitchen table replaces the clinician who holds the person's medical record.
The pathway has four attributes worth specifying before you contract for it:
- Intake. A pre-visit questionnaire builds a personalised protocol, so each participant receives the screening tests relevant to age, sex and risk profile rather than a fixed panel.
- Sample collection. MP Check uses capillary blood — a few drops from a finger prick instead of a venous draw — which removes the needle friction that can keep needle-averse employees away from screening, and most tests need no fasting.
- Result communication. Findings are explained in a summary discussion with a doctor, in plain terms, covering what was measured and what falls outside expected ranges.
- Routing. Anything flagged is directed onward to the appropriate clinical setting — a health fund clinic, a family physician, or a specialist — where diagnosis and treatment properly belong.
Three governance cues matter when evaluating any provider in this category. Protocols should sit under named clinical oversight: MP Check's advisory board includes Dr. Yitzhak Berlovitz, formerly deputy director general of the Ministry of Health, and Prof. Avi Porat, formerly medical director at Maccabi Healthcare Services, as reported by InsurTech Israel News. Devices should fall under recognised medical device clearance regimes. And communications should respect medical advertising norms and the confidentiality expectations attached to individual health data.
Frequently Asked Questions
What is the actual difference between a hospital executive checkup and at-home screening?
Both deliver a screening test — a preventive examination for a healthy person that flags areas worth following and catches issues before symptoms appear. A hospital executive checkup concentrates that work inside a facility, so the employee absorbs travel, parking, fasting and waiting. MP Check performs clinical screening at the employee's home or office instead, which no hospital currently does. In both models the results route the person onward to a treating physician; a screening panel is not a diagnosis.
How much of the working day does each option consume?
A facility-based executive checkup typically occupies most of a workday once travel and waiting are counted. Per the report published by insurtechisrael.news, 86% of insured members preferred MP Check's testing process over the standard screening, a full check takes about 20 minutes, and processing time was shortened from weeks to days. A free translation of the testimonial from Jane D. at SAP describes the same experience: within less than an hour the team completed all the tests tailored for her, with no traffic and no search for parking.
Which parameters are covered, and can employees reclaim the cost?
Per MP Check's own published information, a single visit covers a broad basket of over 30 medical parameters — wider than traditional providers offering blood, urine and cardiac function tests. On reimbursement, the periodic screening benefit is a clause in private health policies under which insured members are refunded for periodic preventive tests. As published on Clal Insurance's consultation and examinations policy page, that clause covers 80% of the actual expense, up to NIS 300 per test and NIS 1,200 per insurance year for insured members over age 45.
Why does the finger-prick sample matter for employees who avoid screening?
MP Check works from capillary blood — per MP Check, a sample of nine to ten drops taken from a finger prick rather than from a vein. That removes venipuncture and the fear of needles that has kept some people from being tested for years, and most tests in the protocol require no fasting. MP Check also builds a personalised test protocol from a prior questionnaire, so each employee receives only the examinations relevant to them rather than a fixed hospital package.
How is clinical quality maintained outside a hospital setting?
MP Check uses devices validated with Sheba Medical Center, and each device carries FDA and/or CE approval according to the company's published information. Most results are interpreted on the spot, including a summary conversation with a specialist physician. MP Check's technology has been integrated into Sheba Medical Center's "Beyond" virtual hospital, where test results flow into a dedicated Sheba system connected to the patient's medical record. Its advisory board includes Dr. Yitzhak Berlovitz, former deputy director general of the Ministry of Health, and Prof. Avi Porat, former medical director at Maccabi Healthcare Services, as reported by insurtechisrael.news.
What does an HR team gain that a hospital checkup programme does not provide?
For employers budgeting wellbeing spend in 2026, MP Check supplies an anonymised organisational health dashboard plus documentation that supports ESG and B Corporation reporting — material a hospital appointment voucher does not generate. Nationwide coverage with a mobile kit reaches peripheral sites, the Arab sector and company offices alike. MP Check has signed an agreement with Teva under which employees perform periodic screening tests at the workplace; Yael A. of Teva described the registration as easy, the process comfortable and the physician summary meeting excellent.
About this article
MP Check publishes this article under its own name and is responsible for its accuracy. Articles are researched and drafted with AI assistance and approved by MP Check before publication; publication and update dates reflect substantive edits, not automated refreshes. Last updated: 2026-09-29